ARO-DM1 Intravenous (IV) Infusion
ARODM1-1001
Phase 2 small_molecule active
Quick answer
ARO-DM1 Intravenous (IV) Infusion for Myotonic Dystrophy 1 is a Phase 2 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- Myotonic Dystrophy 1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active